Enhancing Predictive Capabilities With Complex Human Cell-Based Models

Enhancing Predictive Capabilities With Complex Human Cell-Based Models Advanced in vitro models are reducing reliance on animal testing, enabling researchers to develop and test critical disease-treating drugs and therapies in biologically relevant systems. This webinar will explore how primary human cells support drug discovery and preclinical pharmaceutical research, including toxicity and safety testing and analyzing the pharmacokinetics of new compounds. 1. Receive an introduction to how primary cells and media can be utilized for optimized screening and testing 2. Learn how biologically relevant and predictive models can be built using the co-culture of primary cells 3. Understand the benefits of 3D cell models 4. Discover Lonza’s portfolio of primary human cells, media and reagents that support drug discovery Kevin Grady Associate Director, Marketing Strategy Lonza Manisha Nautiyal, PhD Principal Scientist Lonza